CN112567050A - 检测方法 - Google Patents

检测方法 Download PDF

Info

Publication number
CN112567050A
CN112567050A CN201980051265.5A CN201980051265A CN112567050A CN 112567050 A CN112567050 A CN 112567050A CN 201980051265 A CN201980051265 A CN 201980051265A CN 112567050 A CN112567050 A CN 112567050A
Authority
CN
China
Prior art keywords
subject
fecal
rna
biomarker
colorectal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201980051265.5A
Other languages
English (en)
Chinese (zh)
Inventor
安德鲁·巴内尔
埃丽卡·巴内尔
康毅明
伊丽莎白·沃兹勒
卡蒂·坎贝尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gene Replication Co ltd
Original Assignee
Geneoscopy LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geneoscopy LLC filed Critical Geneoscopy LLC
Publication of CN112567050A publication Critical patent/CN112567050A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
CN201980051265.5A 2018-06-01 2019-05-31 检测方法 Pending CN112567050A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862679621P 2018-06-01 2018-06-01
US62/679,621 2018-06-01
US201962797763P 2019-01-28 2019-01-28
US62/797,763 2019-01-28
PCT/US2019/035061 WO2019232483A1 (en) 2018-06-01 2019-05-31 Detection method

Publications (1)

Publication Number Publication Date
CN112567050A true CN112567050A (zh) 2021-03-26

Family

ID=68698469

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980051265.5A Pending CN112567050A (zh) 2018-06-01 2019-05-31 检测方法

Country Status (8)

Country Link
US (3) US20210214797A1 (https=)
EP (1) EP3802885A4 (https=)
JP (1) JP7650663B2 (https=)
CN (1) CN112567050A (https=)
AU (1) AU2019276577B2 (https=)
CA (1) CA3136405A1 (https=)
IL (1) IL279125B2 (https=)
WO (1) WO2019232483A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115602326A (zh) * 2022-10-21 2023-01-13 中国科学院计算技术研究所（Cn） 一种用于挖掘肿瘤标志物的方法以及肿瘤风险筛查方法

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2986412T3 (es) 2016-10-27 2024-11-11 Geneoscopy Inc Método de aislamiento de ácidos nucleicos eucariotas a partir de muestras de heces
EP4426860A4 (en) * 2021-11-01 2025-11-12 Univ Colorado State Res Found DIRECT NON-INVASIVE PROTEOMIC PROFILING USING STOOL SAMPLES FOR THE DIAGNOSIS OF GASTROINTESTINAL DISEASES
KR102425034B1 (ko) * 2021-12-14 2022-07-27 주식회사 에이아이더뉴트리진 표적 바이러스 검출을 위한 페이퍼 멤브레인 기반 현장용 rna 추출 플랫폼
WO2024108271A1 (en) * 2022-11-25 2024-05-30 Denis King Colorectal cancer risk assessment
EP4654960A1 (en) * 2023-01-26 2025-12-03 Mayo Foundation for Medical Education and Research Assessing and treating mammals having polyps
US20260060660A1 (en) 2024-08-30 2026-03-05 Geneoscopy, Inc. Compositions and methods for immunological testing of stool

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101680025A (zh) * 2007-01-09 2010-03-24 癌甲基化组科学公司 选定基因中的表观遗传变化和癌症
CN103324846A (zh) * 2013-06-13 2013-09-25 浙江加州国际纳米技术研究院绍兴分院 结直肠癌症治疗预后生物标记物的筛选方法
CN107849107A (zh) * 2015-08-05 2018-03-27 伊玛提克斯生物技术有限公司 用于前列腺癌和其他癌症免疫治疗的新型肽和肽组合物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4033820B2 (ja) 2003-07-29 2008-01-16 株式会社日立製作所 細胞回収方法
JP2007175021A (ja) 2005-12-28 2007-07-12 Sysmex Corp 大腸がんのリンパ節転移マーカー
EP1862803A1 (en) 2006-06-02 2007-12-05 Atlas Antibodies AB Use of protein SATB2 as a marker for colorectal cancer
WO2007149269A2 (en) 2006-06-12 2007-12-27 Oncomethylome Sciences S.A. Methylation markers for early detection and prognosis of colon cancers
US20100196889A1 (en) * 2006-11-13 2010-08-05 Bankaitis-Davis Danute M Gene Expression Profiling for Identification, Monitoring and Treatment of Colorectal Cancer
JPWO2008093530A1 (ja) 2007-01-30 2010-05-20 国立大学法人浜松医科大学 大腸癌病期検出方法
FR2919062B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal.
WO2009042676A1 (en) 2007-09-24 2009-04-02 University Of South Florida Method for early detection of cancers
EP2287331A4 (en) 2008-05-12 2012-01-25 Olympus Corp PROCESS FOR PROCESSING EXCREMENTS AND CONTAINERS FOR PROCESSING EXCREMENTS
CN102105583A (zh) 2008-07-23 2011-06-22 奥林巴斯株式会社 从粪便试样中回收核酸的方法、核酸分析方法以及粪便试样处理装置
WO2010042903A1 (en) 2008-10-09 2010-04-15 Alfagene Bioscience, Inc Use and identification of biomarkers for gastrointestinal diseases
WO2010053539A2 (en) * 2008-11-05 2010-05-14 The Texas A&M University System Methods for detecting colorectal diseases and disorders
JPWO2010134246A1 (ja) 2009-05-20 2012-11-08 オリンパス株式会社 核酸含有試料の調製方法
JPWO2010134245A1 (ja) 2009-05-20 2012-11-08 オリンパス株式会社 哺乳細胞由来核酸の回収方法、核酸解析方法、及び採便用キット
EP2655661B1 (en) * 2010-12-23 2015-03-11 Agendia N.V. Methods and means for molecular classification of colorectal cancers
AU2012301589A1 (en) * 2011-08-31 2014-02-27 Oncocyte Corporation Methods and compositions for the treatment and diagnosis of colorectal cancer
KR102175688B1 (ko) 2013-03-27 2020-11-06 제넨테크, 인크. 베타7 인테그린 길항제를 사용하는 위장 염증성 장애의 치료를 평가하기 위한 바이오마커의 사용
US11035006B2 (en) 2013-07-30 2021-06-15 H. Lee Moffitt Cancer Center And Research Institute, Inc. Colorectal cancer recurrence gene expression signature
US20180282815A1 (en) 2015-04-29 2018-10-04 Geneoscopy, Llc Colorectal cancer screening method and device
ES2986412T3 (es) * 2016-10-27 2024-11-11 Geneoscopy Inc Método de aislamiento de ácidos nucleicos eucariotas a partir de muestras de heces

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101680025A (zh) * 2007-01-09 2010-03-24 癌甲基化组科学公司 选定基因中的表观遗传变化和癌症
CN103324846A (zh) * 2013-06-13 2013-09-25 浙江加州国际纳米技术研究院绍兴分院 结直肠癌症治疗预后生物标记物的筛选方法
CN107849107A (zh) * 2015-08-05 2018-03-27 伊玛提克斯生物技术有限公司 用于前列腺癌和其他癌症免疫治疗的新型肽和肽组合物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ELIZABETH HERRING等: "A Stool Multitarget mRNA Assay for the Detection of Colorectal Neoplasms", 《COLORECTAL CANCER》, vol. 1765, 31 March 2018 (2018-03-31), pages 218 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115602326A (zh) * 2022-10-21 2023-01-13 中国科学院计算技术研究所（Cn） 一种用于挖掘肿瘤标志物的方法以及肿瘤风险筛查方法

Also Published As

Publication number Publication date
AU2019276577B2 (en) 2025-09-11
IL279125B1 (en) 2025-11-01
JP2021526375A (ja) 2021-10-07
AU2019276577A1 (en) 2021-01-14
CA3136405A1 (en) 2019-12-05
EP3802885A1 (en) 2021-04-14
WO2019232483A1 (en) 2019-12-05
IL279125B2 (en) 2026-03-01
US20220154291A1 (en) 2022-05-19
EP3802885A4 (en) 2022-03-02
JP7650663B2 (ja) 2025-03-25
US20240093312A1 (en) 2024-03-21
US20210214797A1 (en) 2021-07-15
IL279125A (en) 2021-01-31
US11479824B2 (en) 2022-10-25

Similar Documents

Publication Publication Date Title
US11479824B2 (en) Detection method for cancer using RNA biomarkers
US20210381062A1 (en) Nasal epithelium gene expression signature and classifier for the prediction of lung cancer
ES2611000T3 (es) Método para usar la expresión génica para determinar el pronóstico de cáncer de próstata
CN103403543B (zh) 结肠癌基因表达签名及使用方法
US20250146084A1 (en) Colorectal cancer screening method and device
ES2821300T3 (es) Predicción de pronóstico para el melanoma de cáncer
US20230203591A1 (en) Detection method using eukaryotic cells
BRPI0706511A2 (pt) marcadores de expressão genética para prognóstico de cáncer colorretal
CN104093859A (zh) 多基因生物标志物的鉴定
JP2021526791A (ja) セルフリー核酸の細胞起源を決定するための方法およびシステム
WO2017223216A1 (en) Compositions and methods for diagnosing lung cancers using gene expression profiles
CN110573629A (zh) 用于诊断早期胰腺癌的方法和试剂盒
US20130084241A1 (en) DEVELOPMENT OF miRNA DIAGNOSTICS TOOLS IN BLADDER CANCER
WO2023125788A1 (en) Biomarkers for colorectal cancer treatment
CA3077798C (en) Method of isolating eukaryotic nucleic acid from a stool sample
WO2013130869A1 (en) Gene expression signatures in cancer

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right

Effective date of registration: 20220110

Address after: Missouri, USA

Applicant after: Gene replication Co.,Ltd.

Address before: Missouri, USA

Applicant before: GENEOSCOPY, LLC

TA01 Transfer of patent application right